Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating cancer by administering an antibody that binds transforming growth factor beta (TGF-beta) 1, TGF-beta 2 and TGF-beta 3

Method of treating cancer by administering an antibody that binds transforming growth factor beta (TGF-beta) 1, TGF-beta 2 and TGF-beta 3

US Patent 11098111 · Granted Aug 24, 2021

Estimated economic value: $4,701,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies that bind interleukin-2 and uses thereof2025
Antibodies that bind interleukin-2 and uses thereof2025
Antibodies that bind interleukin-2 and uses thereof2025
Anti-PD-1 antibodies2024
Antibodies that bind transforming growth factor beta (TGF beta) and methods of u2024
Antibodies that bind transforming growth factor beta (TGF beta) and methods of u2024
Antibodies that bind transforming growth factor beta (TGF beta) and methods of u2024
Antibodies that bind transforming growth factor beta (TGF beta) and methods of u2024
Antibodies that bind transforming growth factor beta (TGF beta) and methods of u2024
Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereof2023
Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereof2023
Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereof2023